The exosome-mimics prepared by the T cell membrane, which retained T cell receptors on the surface, could bind to HIV surface glycoprotein gp120 and inhibit gp120-induced CD4+ T cell damage, suggesting a promising therapeutic agent against HIV infection (Wei et al., 2018b). Here, ITIH4 is linked to HIV infectious disease.